-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
ImmunoGen, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2015 to Q3 2023.
- ImmunoGen, Inc. Return On Equity for the quarter ending September 30, 2023 was -22.1 %, a 70.9% increase year-over-year.
- ImmunoGen, Inc. annual Return On Equity for 2022 was -100 %, a 1.62% decline from 2021.
- ImmunoGen, Inc. annual Return On Equity for 2021 was -98.6 %, a 90% increase from 2020.
- ImmunoGen, Inc. annual Return On Equity for 2020 was -983 %, a 709% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)